UPDATE: Jefferies Assumes Phathom Pharmaceuticals (PHAT) at Buy
Tweet Send to a Friend
(Updated - October 21, 2022 8:46 AM EDT)
Jefferies analyst Glen Santangelo assumes coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Glen Santangelo assumes coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
